SCHEMBL6380245

SCHEMBL6380245

O=Cc1ccc(OCCn2ccc3ccccc32)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.54
PPARG P37231 1/20 0.54
CDK4 P11802 4/20 0.51
CCND1 P24385 4/20 0.51
POLB P06746 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
MAPK1 P28482 1/20 0.47
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 1/20 0.44
PKM P14618 1/20 0.44
HTT P42858 1/20 0.44
LTA4H P09960 1/20 0.44
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6382619 0.82 FFAR1 (0.51) FFAR1PPARGCDK4CCND1MAPK1
SCHEMBL6486637 0.82 LTA4H (0.47) FFAR1PPARGPOLBL3MBTL1SMN1; SMN2
SCHEMBL6486014 0.80 MTNR1A (0.47) POLBL3MBTL1RAB9ASMN1; SMN2LMNA
SCHEMBL6381119 0.80 NPC1 (0.49) FFAR1PPARGPOLBL3MBTL1MAPK1
SCHEMBL4443382 0.78 CDK4 (0.56) FFAR1PPARGCDK4CCND1L3MBTL1
SCHEMBL6383877 0.78 NR1H4 (0.56) FFAR1PPARGPOLBMAPK1RAB9A
SCHEMBL6379239 0.76 SMN1; SMN2 (0.60) FFAR1PPARGL3MBTL1MAPK1RAB9A
SCHEMBL1608367 0.76 ALDH1A1 (0.51) POLBMAPK1SMN1; SMN2LMNAMAPT
SCHEMBL27565238 0.76 CDK4 (0.61) CDK4CCND1MAPK1RAB9ASMN1; SMN2
SCHEMBL6380456 0.76 PPARG (0.57) FFAR1PPARGCDK4CCND1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity SIGMA-TAU INDUSTRIES FARMACEUTICHE RIUNITE S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity LIPC, CPT1A, GPR119 FFAR1 63/4885PPARG 127/4885CDK4 4686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.